Exact Sciences Statistics
Total Valuation
Exact Sciences has a market cap or net worth of $9.79 billion. The enterprise value is $11.55 billion.
Important Dates
The last earnings date was Tuesday, November 5, 2024, after market close.
| Earnings Date | Nov 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Exact Sciences has 185.08 million shares outstanding. The number of shares has increased by 2.17% in one year.
| Current Share Class | 185.08M |
| Shares Outstanding | 185.08M |
| Shares Change (YoY) | +2.17% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 0.67% |
| Owned by Institutions (%) | 102.33% |
| Float | 183.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.60 |
| Forward PS | 3.12 |
| PB Ratio | 3.05 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 99.49 |
| P/OCF Ratio | 42.02 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 117.37 |
Financial Position
The company has a current ratio of 2.12, with a Debt / Equity ratio of 0.87.
| Current Ratio | 2.12 |
| Quick Ratio | 1.78 |
| Debt / Equity | 0.87 |
| Debt / EBITDA | 79.00 |
| Debt / FCF | 28.26 |
| Interest Coverage | -8.98 |
Financial Efficiency
Return on equity (ROE) is -6.76% and return on invested capital (ROIC) is -2.43%.
| Return on Equity (ROE) | -6.76% |
| Return on Assets (ROA) | -2.16% |
| Return on Capital (ROIC) | -2.43% |
| Revenue Per Employee | $407,928 |
| Profits Per Employee | -$32,430 |
| Employee Count | 6,600 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 5.40 |
Taxes
In the past 12 months, Exact Sciences has paid $3.47 million in taxes.
| Income Tax | 3.47M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.77% in the last 52 weeks. The beta is 1.27, so Exact Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 1.27 |
| 52-Week Price Change | -18.77% |
| 50-Day Moving Average | 64.79 |
| 200-Day Moving Average | 58.13 |
| Relative Strength Index (RSI) | 35.92 |
| Average Volume (20 Days) | 3,626,768 |
Short Selling Information
The latest short interest is 14.06 million, so 7.60% of the outstanding shares have been sold short.
| Short Interest | 14.06M |
| Short Previous Month | 15.54M |
| Short % of Shares Out | 7.60% |
| Short % of Float | 7.65% |
| Short Ratio (days to cover) | 9.68 |
Income Statement
In the last 12 months, Exact Sciences had revenue of $2.69 billion and -$214.04 million in losses. Loss per share was -$1.17.
| Revenue | 2.69B |
| Gross Profit | 1.96B |
| Operating Income | -227.22M |
| Pretax Income | -172.10M |
| Net Income | -214.04M |
| EBITDA | -11.34M |
| EBIT | -227.22M |
| Loss Per Share | -$1.17 |
Full Income StatementBalance Sheet
The company has $1.02 billion in cash and $2.78 billion in debt, giving a net cash position of -$1.76 billion or -$9.51 per share.
| Cash & Cash Equivalents | 1.02B |
| Total Debt | 2.78B |
| Net Cash | -1.76B |
| Net Cash Per Share | -$9.51 |
| Equity (Book Value) | 3.21B |
| Book Value Per Share | 17.35 |
| Working Capital | 809.46M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $233.02 million and capital expenditures -$134.60 million, giving a free cash flow of $98.43 million.
| Operating Cash Flow | 233.02M |
| Capital Expenditures | -134.60M |
| Free Cash Flow | 98.43M |
| FCF Per Share | $0.53 |
Full Cash Flow StatementMargins
Gross margin is 72.96%, with operating and profit margins of -8.44% and -7.95%.
| Gross Margin | 72.96% |
| Operating Margin | -8.44% |
| Pretax Margin | -7.82% |
| Profit Margin | -7.95% |
| EBITDA Margin | -0.42% |
| EBIT Margin | -8.44% |
| FCF Margin | -0.57% |
Dividends & Yields
Exact Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.17% |
| Shareholder Yield | -2.17% |
| Earnings Yield | -2.19% |
| FCF Yield | 1.01% |
Dividend DetailsAnalyst Forecast
The average price target for Exact Sciences is $73.07, which is 38.10% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $73.07 |
| Price Target Difference | 38.10% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 12.07% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Exact Sciences has an Altman Z-Score of 1.53 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.53 |
| Piotroski F-Score | 3 |